Biotest AG
Biotest AG: Publication of the offer document on the voluntary public tender for Biotest AG by CREAT Group
DGAP-News: Biotest AG / Key word(s): Offer PRESS RELEASE – Offer document reaffirms the offer announced on April 7, 2017 – The Management Board and the Supervisory Board welcome and support the offer – The Management Board and the Supervisory Board will carefully review the offer document and issue a reasoned opinion pursuant to Section 27 WpÜG. – The acceptance period will run from May 18, 2017, and is expected to end on June 15, 2017
The Management Board and the Supervisory Board will review the offer document carefully, bearing in mind the Company’s best interests, and issue a reasoned opinion on the offer pursuant to Section 27 of the German Securities Acquisition and Transfer Act (WpÜG). Both boards welcome and support the offer. Today’s publication of the offer document marks the start of the acceptance period, which is expected to end on June 15, 2017.
IR contact PR contact Ordinary shares: securities’ ID No. 522720; ISIN DE0005227201 Disclaimer
18.05.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | Biotest AG |
Landsteinerstraße 5 | |
63303 Dreieich | |
Germany | |
Phone: | 0 61 03 – 8 01-0 |
Fax: | 0 61 03 – 8 01-150 |
E-mail: | investor_relations@biotest.de |
Internet: | http://www.biotest.de |
ISIN: | DE0005227235, DE0005227201 |
WKN: | 522723, 522720 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
End of News | DGAP News Service |